secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK:        0001439222
Form:       8-K
Filed at:   2022-09-07T23:59:59+00:00
Accession:  0001193125-22-239454
Event type: leadership
Sentiment:  negative
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Agios Pharma CFO Jonathan Biller resigns effective Sept 16
----------------------------------------------------------

- Jonathan Biller notified resignation as CFO, head of corporate affairs, effective Sept 16, 2022.
- Resignation is to pursue other opportunities; no successor named as of filing date.
- Biller served as principal financial officer; departure creates CFO vacancy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522239454/0001193125-22-239454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522239454/d388647d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-239454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer